Carlos Camps
Has grant
SpainResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Recent Grants
Grant: Close
CIBEROnc
Open Date: 2017-01-01
Close Date: 2019-12-01
Grant: Close
DETECCIÓN MÉDICA CON ANIMALES PREVENCAN
Open Date: 2017-01-01
Close Date: 2018-12-01
Grant: Close
Caracterización de la Interacción entre Célula Madre Tumoral y Microambiente Inmune en el Cáncer de Pulmón no Microcítico. Implicaciones Traslacionales.
Open Date: 2016-01-01
Close Date: 2019-12-01
Grant: Close
Aplicación De La Metabolómica En El Descubrimiento De Nuevos Biomarcadores En Cáncer De Pulmón No Microcítico. Applications of metabolomics for the discovery of new biomarkers in non small cell lung cancer
Open Date: 2015-05-01
Close Date: 2016-05-01
Grant: Close
Descubrimiento y desarrollo biomarcadores innovadores para medicina personalizada y terapias para el tratamiento eficaz del cáncer de pulmón.
Open Date: 2014-07-01
Close Date: 2017-07-01
Articles (9)
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Aim: To evaluate the quality of life (QoL) in patients with breakthrough cancer pain (BTcP) in Spanish medical oncology departments. Patients & methods: In a prospective, observational, multicenter study, we assessed QoL using the EQ-5D-5L instrument at baseline and after 15 and 30 days of individualized BTcP therapy, as well as BTcP characteristics and treatment. Results: Patients (n = 118) were mainly women, over 64 years old and with advanced cancer. QoL improved at 15 (p = 0.013) and 30 days (p = 0.011) versus baseline. Individualized BTcP therapy consisted mostly of rapid-onset opioids (transmucosal fentanyl at doses of 67–800 μg) according to the physician evaluation. BTcP improved, including statistically significant reductions in intensity, duration, number of episodes in the last 24 h and time to onset of BTcP relief. Conclusion: QoL increased after individualized pain therapy in patients with advanced cancer and BTcP in medical oncology departments.
Year:
2022
Year:
2021
Year:
2021
Year:
2020
Year:
2020
Collaborators (7)
ALFREDO CARRATO
Oncology Emeritus Professor, Alcala University
Universidad de Alcalá
Rafael Sirera
Professor
Universitat Politècnica de València
VEGA IRANZO GONZALEZ-CRUZ
Profesora Asociada Universitaria
University of Valencia
Jesus M Paramio
Head of the Molecular and translational Oncology Division
Centro de Investigaciones Energéticas Medioambientales y Tecnológicas
Eloisa Jantus Lewintre
Profesora titular
Universitat Politècnica de València
EVA SERNA GARCIA
Profesora Contratada Doctor
University of Valencia
Andrea Moreno Manuel
Instituto de Investigación Sanitaria Aragón
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.